From chemistry-request@ccl.net Fri Jul  2 15:55:05 2004
Received: from schrodinger.com (thermidore.schrodinger.com [192.156.98.99])
	by server.ccl.net (8.12.8/8.12.8) with ESMTP id i62Kt0FY022761
	for <chemistry..at..ccl.net>; Fri, 2 Jul 2004 15:55:04 -0500
Received: from SVETLA (svetla.schrodinger.com [192.156.98.141])
	by schrodinger.com (8.12.6/8.12.8) with SMTP id i62L0O27008207
	for <chemistry..at..ccl.net>; Fri, 2 Jul 2004 14:00:25 -0700 (PDT)
	(envelope-from announce..at..schrodinger.com)
From: Schrodinger Announcements <announce..at..schrodinger.com>
To: CCL <chemistry..at..ccl.net>
Subject: Schrodinger Drug Design Seminar in WA, July 28
Date: Fri, 02 Jul 2004 16:57:26 -0400
Message-ID: <0702104165726.138@SVETLA>
X-Spam-Status: No, hits=1.0 required=7.5 tests=NO_COST autolearn=no 
	version=2.61
X-Spam-Checker-Version: SpamAssassin 2.61 (1.212.2.1-2003-12-09-exp) on 
	servernd.ccl.net

Schrodinger is hosting a seminar on Wednesday, July 28, at the
Doubletree
Hotel Bellevue in Bellevue, Washington.

The Summer 2004 Drug Design Seminar will feature presentations on our
latest advances and applications in structure-based and ligand-based
drug
design.

There is no charge for attending, but space is limited, so please
register in advance at our website:

http://www.schrodinger.com/Announce/Workshop/W2004/wa_seminar04.html